The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
Comparative Analysis of Measures of Viral Reservoirs in HIV-1 Eradication Studies
Open accessAbstract
HIV-1 reservoirs preclude virus eradication in patients receiving highly active antiretroviral therapy (HAART). The best characterized reservoir is a small, difficult-to-quantify pool of resting memory CD4(+) T cells carrying latent but replication-competent viral genomes. Because strategies targeting this latent reservoir are now being tested in clinical trials, well-validated high-throughput assays that quantify this reservoir are urgently needed. Here we compare eleven different approaches for quantitating persistent HIV-1 in 30 patients on HAART, using the original viral outgrowth assay for resting CD4(+) T cells carrying inducible, replication-competent viral genomes as a standard for comparison. PCR-based assays for cells containing HIV-1 DNA gave infected cell frequencies at least 2 logs higher than the viral outgrowth assay, even in subjects who started HAART during acute/early infection. This difference may reflect defective viral genomes. The ratio of infected cell frequencies determined by viral outgrowth and PCR-based assays varied dramatically between patients. Although strong correlations with the viral outgrowth assay could not be formally excluded for most assays, correlations achieved statistical significance only for integrated HIV-1 DNA in peripheral blood mononuclear cells and HIV-1 RNA/DNA ratio in rectal CD4(+) T cells. Residual viremia was below the limit of detection in many subjects and did not correlate with the viral outgrowth assays. The dramatic differences in infected cell frequencies and the lack of a precise correlation between culture and PCR-based assays raise the possibility that the successful clearance of latently infected cells may be masked by a larger and variable pool of cells with defective proviruses. These defective proviruses are detected by PCR but may not be affected by reactivation strategies and may not require eradication to accomplish an effective cure. A molecular understanding of the discrepancy between infected cell frequencies measured by viral outgrowth versus PCR assays is an urgent priority in HIV-1 cure research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents
(1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-12_part_2-199806151-00003 · Cited by 5,209
Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy
Finzi, D., Hermankova, M., Pierson, T., Carruth, L. M., Buck, C., Chaisson, R. E., Quinn, T. C., Chadwick, K., Margolick, J., Brookmeyer, R., et al. (1997) · Science · doi:10.1126/science.278.5341.1295 · Cited by 3,098
Self-citationHammer, S. M., Squires, K. E., Hughes, M. D., Grimes, J. M., Demeter, L. M., Currier, J. S., Eron, J. J., Feinberg, J. E., Balfour, H. H., Deyton, L. R., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709113371101 · Cited by 2,640
Recovery of replication-competent HIV despite prolonged suppression of plasma viremia
Wong, J. K., Hezareh, M., Günthard, H. F., Havlir, D. V., Ignacio, C. C., Spina, C. A., & Richman, D. D. (1997) · Science · doi:10.1126/science.278.5341.1291 · Cited by 2,186
Self-citationFinzi, D., Blankson, J., Siliciano, J. D., Margolick, J. B., Chadwick, K., Pierson, T., Smith, K., Lisziewicz, J., Lori, F., Flexner, C., et al. (1999) · Nature Medicine · doi:10.1038/8394 · Cited by 2,119
Self-citationQuantification of latent tissue reservoirs and total body viral load in HIV-1 infection
Chun, T.-W., Carruth, L., Finzi, D., Shen, X., DiGiuseppe, J. A., Taylor, H., Hermankova, M., Chadwick, K., Margolick, J., Quinn, T. C., et al. (1997) · Nature · doi:10.1038/387183a0 · Cited by 2,050
Self-citationPresence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy
Chun, T.-W., Stuyver, L., Mizell, S. B., Ehler, L. A., Mican, J. A. M., Baseler, M., Lloyd, A. L., Nowak, M. A., & Fauci, A. S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13193 · Cited by 1,977
Gulick, R. M., Mellors, J. W., Havlir, D., Eron, J. J., Gonzalez, C., McMahon, D., Richman, D. D., Valentine, F. T., Jonas, L., Meibohm, A., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709113371102 · Cited by 1,885
Self-citationDecay characteristics of HIV-1-infected compartments during combination therapy
Perelson, A. S., Essunger, P., Cao, Y., Vesanen, M., Hurley, A., Saksela, K., Markowitz, M., & Ho, D. D. (1997) · Nature · doi:10.1038/387188a0 · Cited by 1,880
Brenchley, J. M., Schacker, T. W., Ruff, L. E., Price, D. A., Taylor, J. H., Beilman, G. J., Nguyen, P. L., Khoruts, A., Larson, M., Haase, A. T., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040874 · Cited by 1,832
Siliciano, J. D., Kajdas, J., Finzi, D., Quinn, T. C., Chadwick, K., Margolick, J. B., Kovacs, C., Gange, S. J., & Siliciano, R. F. (2003) · Nature Medicine · doi:10.1038/nm880 · Cited by 1,703
Self-citationZack, J. A., Arrigo, S. J., Weitsman, S. R., Go, A. S., Haislip, A., & Chen, I. S. Y. (1990) · Cell · doi:10.1016/0092-8674(90)90802-l · Cited by 1,517
Veazey, R. S., DeMaria, M., Chalifoux, L. V., Shvetz, D. E., Pauley, D. R., Knight, H. L., Rosenzweig, M., Johnson, R. P., Desrosiers, R. C., & Lackner, A. A. (1998) · Science · doi:10.1126/science.280.5362.427 · Cited by 1,407
Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection
Mattapallil, J. J., Douek, D. C., Hill, B., Nishimura, Y., Martin, M., & Roederer, M. (2005) · Nature · doi:10.1038/nature03501 · Cited by 1,278
Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy
Archin, N. M., Liberty, A. L., Kashuba, A. D., Choudhary, S. K., Kuruc, J. D., Crooks, A. M., Parker, D. C., Anderson, E. M., Kearney, M. F., Strain, M. C., et al. (2012) · Nature · doi:10.1038/nature11286 · Cited by 1,139
Self-citationDepartment of Health and Human Services
(2002) · Handbook of Research Design & Social Measurement · doi:10.4135/9781412984386.n104 · Cited by 1,032
Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells
Li, Q., Duan, L., Estes, J. D., Ma, Z.-M., Rourke, T., Wang, Y., Reilly, C., Carlis, J., Miller, C. J., & Haase, A. T. (2005) · Nature · doi:10.1038/nature03513 · Cited by 952
Guadalupe, M., Reay, E., Sankaran, S., Prindiville, T., Flamm, J., McNeil, A., & Dandekar, S. (2003) · Journal of Virology · doi:10.1128/jvi.77.21.11708-11717.2003 · Cited by 866
Davey, R. T., Bhat, N., Yoder, C., Chun, T.-W., Metcalf, J. A., Dewar, R., Natarajan, V., Lempicki, R. A., Adelsberger, J. W., Miller, K. D., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.15109 · Cited by 849
Chun, T.-W., Engel, D., Berrey, M. M., Shea, T., Corey, L., & Fauci, A. S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8869 · Cited by 846
The Challenge of Finding a Cure for HIV Infection
Richman, D. D., Margolis, D. M., Delaney, M., Greene, W. C., Hazuda, D., & Pomerantz, R. J. (2009) · Science · doi:10.1126/science.1165706 · Cited by 846
Self-citationIn vivo fate of HIV-1-infected T cells: Quantitative analysis of the transition to stable latency
Chun, T.-W., Finzi, D., Margolick, J., Chadwick, K., Schwartz, D., & Siliciano, R. F. (1995) · Nature Medicine · doi:10.1038/nm1295-1284 · Cited by 787
Self-citationLow-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy
Palmer, S., Maldarelli, F., Wiegand, A., Bernstein, B., Hanna, G. J., Brun, S. C., Kempf, D. J., Mellors, J. W., Coffin, J. M., & King, M. S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800050105 · Cited by 638
Self-citationPalmer, S., Wiegand, A. P., Maldarelli, F., Bazmi, H., Mican, J. M., Polis, M., Dewar, R. L., Planta, A., Liu, S., Metcalf, J. A., et al. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.10.4531-4536.2003 · Cited by 604
Self-citationQuiescent T Lymphocytes as an Inducible Virus Reservoir in HIV-1 Infection
Bukrinsky, M. I., Stanwick, T. L., Dempsey, M. P., & Stevenson, M. (1991) · Science · doi:10.1126/science.1925601 · Cited by 590
Persistence of HIV in Gut‐Associated Lymphoid Tissue despite Long‐Term Antiretroviral Therapy
Chun, T., Nickle, D. C., Justement, J. S., Meyers, J. H., Roby, G., Hallahan, C. W., Kottilil, S., Moir, S., Mican, J. M., Mullins, J. I., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/527324 · Cited by 574
Towards an HIV cure: a global scientific strategy
The International AIDS Society Scientific Working Group on HIV Cure (2012) · Nature Reviews Immunology · doi:10.1038/nri3262 · Cited by 554
J Buzón, M., Massanella, M., Llibre, J. M., Esteve, A., Dahl, V., Puertas, M. C., Gatell, J. M., Domingo, P., Paredes, R., Sharkey, M., et al. (2010) · Nature Medicine · doi:10.1038/nm.2111 · Cited by 551
Self-citationDepletion of latent HIV-1 infection in vivo: a proof-of-concept study
Lehrman, G., Hogue, I. B., Palmer, S., Jennings, C., Spina, C. A., Wiegand, A., Landay, A. L., Coombs, R. W., Richman, D. D., Mellors, J. W., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67098-5 · Cited by 510
Self-citationHighly Precise Measurement of HIV DNA by Droplet Digital PCR
Strain, M. C., Lada, S. M., Luong, T., Rought, S. E., Gianella, S., Terry, V. H., Spina, C. A., Woelk, C. H., & Richman, D. D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055943 · Cited by 504
Self-citationDornadula, G. (1999) · JAMA · doi:10.1001/jama.282.17.1627 · Cited by 463
Dinoso, J. B., Kim, S. Y., Wiegand, A. M., Palmer, S. E., Gange, S. J., Cranmer, L., O'Shea, A., Callender, M., Spivak, A., Brennan, T., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903107106 · Cited by 441
Self-citationSharkey, M. E., Teo, I., Greenough, T., Sharova, N., Luzuriaga, K., Sullivan, J. L., Bucy, R. P., Kostrikis, L. G., Haase, A., Veryard, C., et al. (2000) · Nature Medicine · doi:10.1038/71569 · Cited by 428
Bailey, J. R., Sedaghat, A. R., Kieffer, T., Brennan, T., Lee, P. K., Wind-Rotolo, M., Haggerty, C. M., Kamireddi, A. R., Liu, Y., Lee, J., et al. (2006) · Journal of Virology · doi:10.1128/jvi.00591-06 · Cited by 417
Self-citationEpigenetic Regulation of HIV-1 Latency by Cytosine Methylation
Kauder, S. E., Bosque, A., Lindqvist, A., Planelles, V., & Verdin, E. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000495 · Cited by 374
Induction of HIV-1 Replication in Latently Infected CD4+ T Cells Using a Combination of Cytokines
Chun, T.-W., Engel, D., Mizell, S. B., Ehler, L. A., & Fauci, A. S. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.1.83 · Cited by 359
Expression of Latent HIV Induced by the Potent HDAC Inhibitor Suberoylanilide Hydroxamic Acid
Archin, N. M., Espeseth, A., Parker, D., Cheema, M., Hazuda, D., & Margolis, D. M. (2009) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2008.0191 · Cited by 336
ART Suppresses Plasma HIV-1 RNA to a Stable Set Point Predicted by Pretherapy Viremia
Maldarelli, F., Palmer, S., King, M. S., Wiegand, A., Polis, M. A., Mican, J., Kovacs, J. A., Davey, R. T., Rock-Kress, D., Dewar, R., et al. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030046 · Cited by 333
Self-citationCpG Methylation Controls Reactivation of HIV from Latency
Blazkova, J., Trejbalova, K., Gondois-Rey, F., Halfon, P., Philibert, P., Guiguen, A., Verdin, E., Olive, D., Van Lint, C., Hejnar, J., et al. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000554 · Cited by 333
Kulkosky, J., Culnan, D. M., Roman, J., Dornadula, G., Schnell, M., Boyd, M. R., & Pomerantz, R. J. (2001) · Blood · doi:10.1182/blood.v98.10.3006 · Cited by 329
Han, Y., Lassen, K., Monie, D., Sedaghat, A. R., Shimoji, S., Liu, X., Pierson, T. C., Margolick, J. B., Siliciano, R. F., & Siliciano, J. D. (2004) · Journal of Virology · doi:10.1128/jvi.78.12.6122-6133.2004 · Cited by 327
Self-citationProstratin Antagonizes HIV Latency by Activating NF-κB
Williams, S. A., Chen, L.-F., Kwon, H., Fenard, D., Bisgrove, D., Verdin, E., & Greene, W. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402124200 · Cited by 318
Gandhi, R. T., Zheng, L., Bosch, R. J., Chan, E. S., Margolis, D. M., Read, S., Kallungal, B., Palmer, S., Medvik, K., Lederman, M. M., et al. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000321 · Cited by 304
Self-citationYukl, S. A., Gianella, S., Sinclair, E., Epling, L., Li, Q., Duan, L., Choi, A. L. M., Girling, V., Ho, T., Li, P., et al. (2010) · The Journal of Infectious Diseases · doi:10.1086/656722 · Cited by 296
Self-citationHIV rebounds from latently infected cells, rather than from continuing low-level replication
Joos, B., Fischer, M., Kuster, H., Pillai, S. K., Wong, J. K., Böni, J., Hirschel, B., Weber, R., Trkola, A., Günthard, H. F., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804192105 · Cited by 294
Self-citationChun, T.-W. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26197 · Cited by 278
Suberoylanilide Hydroxamic Acid Reactivates HIV from Latently Infected Cells
Contreras, X., Schweneker, M., Chen, C.-S., McCune, J. M., Deeks, S. G., Martin, J., & Peterlin, B. M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m807898200 · Cited by 277
Self-citationChun, T.-W., Justement, J. S., Murray, D., Hallahan, C. W., Maenza, J., Collier, A. C., Sheth, P. M., Kaul, R., Ostrowski, M., Moir, S., et al. (2010) · AIDS · doi:10.1097/qad.0b013e328340a239 · Cited by 276
Yang, H.-C., Xing, S., Shan, L., O’Connell, K., Dinoso, J., Shen, A., Zhou, Y., Shrum, C. K., Han, Y., Liu, J. O., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39199 · Cited by 258
Self-citationStrain, M. C., Günthard, H. F., Havlir, D. V., Ignacio, C. C., Smith, D. M., Leigh-Brown, A. J., Macaranas, T. R., Lam, R. Y., Daly, O. A., Fischer, M., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0736332100 · Cited by 254
Self-citationWang, F.-X., Xu, Y., Sullivan, J., Souder, E., Argyris, E. G., Acheampong, E. A., Fisher, J., Sierra, M., Thomson, M. M., Najera, R., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522574 · Cited by 252
Transcriptional Interference Antagonizes Proviral Gene Expression to Promote HIV Latency
Lenasi, T., Contreras, X., & Peterlin, B. M. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.05.016 · Cited by 245
Siliciano, J. D., & Siliciano, R. F. (2005) · Human Retrovirus Protocols · doi:10.1385/1-59259-907-9:003 · Cited by 242
Self-citationHuman Immunodeficiency Virus cDNA Metabolism: Notable Stability of Two-Long Terminal Repeat Circles
Butler, S. L., Johnson, E. P., & Bushman, F. D. (2002) · Journal of Virology · doi:10.1128/jvi.76.8.3739-3747.2002 · Cited by 238
Pierson, T. C., Zhou, Y., Kieffer, T. L., Ruff, C. T., Buck, C., & Siliciano, R. F. (2002) · Journal of Virology · doi:10.1128/jvi.76.17.8518-8513.2002 · Cited by 233
Self-citationMcMahon, D., Jones, J., Wiegand, A., Gange, S. J., Kearney, M., Palmer, S., McNulty, S., Metcalf, J. A., Acosta, E., Rehm, C., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/650749 · Cited by 223
Self-citationHan, Y., Lin, Y. B., An, W., Xu, J., Yang, H.-C., O'Connell, K., Dordai, D., Boeke, J. D., Siliciano, J. D., & Siliciano, R. F. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.06.008 · Cited by 215
Self-citationA Sensitive, Quantitative Assay for Human Immunodeficiency Virus Type 1 Integration
O'Doherty, U., Swiggard, W. J., Jeyakumar, D., McGain, D., & Malim, M. H. (2002) · Journal of Virology · doi:10.1128/jvi.76.21.10942-10950.2002 · Cited by 209
Self-citationEffects of Prostratin on T-Cell Activation and Human Immunodeficiency Virus Latency
Korin, Y. D., Brooks, D. G., Brown, S., Korotzer, A., & Zack, J. A. (2002) · Journal of Virology · doi:10.1128/jvi.76.16.8118-8123.2002 · Cited by 208
Kinetics of Human Immunodeficiency Virus Type 1 Decay following Entry into Resting CD4 + T Cells
Zhou, Y., Zhang, H., Siliciano, J. D., & Siliciano, R. F. (2005) · Journal of Virology · doi:10.1128/jvi.79.4.2199-2210.2005 · Cited by 199
Self-citationXing, S., Bullen, C. K., Shroff, N. S., Shan, L., Yang, H.-C., Manucci, J. L., Bhat, S., Zhang, H., Margolick, J. B., Quinn, T. C., et al. (2011) · Journal of Virology · doi:10.1128/jvi.02033-10 · Cited by 197
Self-citationMolecular Characterization, Reactivation, and Depletion of Latent HIV
Brooks, D. G., Hamer, D. H., Arlen, P. A., Gao, L., Bristol, G., Kitchen, C. M. R., Berger, E. A., & Zack, J. A. (2003) · Immunity · doi:10.1016/s1074-7613(03)00236-x · Cited by 192
Scripture-Adams, D. D., Brooks, D. G., Korin, Y. D., & Zack, J. A. (2002) · Journal of Virology · doi:10.1128/jvi.76.24.13077-13082.2002 · Cited by 183
Pierson, T. C., Kieffer, T. L., Ruff, C. T., Buck, C., Gange, S. J., & Siliciano, R. F. (2002) · Journal of Virology · doi:10.1128/jvi.76.8.4138-4144.2002 · Cited by 180
Self-citationBlankson, J. N., Finzi, D., Pierson, T. C., Sabundayo, B. P., Chadwick, K. R., Margolick, J. B., Quinn, T. C., & Siliciano, R. F. (2000) · The Journal of Infectious Diseases · doi:10.1086/317615 · Cited by 178
Self-citationJosefsson, L., King, M. S., Makitalo, B., Brännström, J., Shao, W., Maldarelli, F., Kearney, M. F., Hu, W.-S., Chen, J., Gaines, H., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1107729108 · Cited by 176
Self-citationKieffer, T. L., Kwon, P., Nettles, R. E., Han, Y., Ray, S. C., & Siliciano, R. F. (2005) · Journal of Virology · doi:10.1128/jvi.79.3.1975-1980.2005 · Cited by 172
Self-citationChun, T.-W., Murray, D., Justement, J. S., Hallahan, C. W., Moir, S., Kovacs, C., & Fauci, A. S. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir208 · Cited by 165
Sánchez, G., Xu, X., Chermann, J., & Hirsch, I. (1997) · Journal of Virology · doi:10.1128/jvi.71.3.2233-2240.1997 · Cited by 162
Detecting HIV-1 integration by repetitive-sampling -gag PCR
Liszewski, M. K., Yu, J. J., & O’Doherty, U. (2009) · Methods · doi:10.1016/j.ymeth.2009.01.002 · Cited by 158
Self-citationGraf, E. H., Mexas, A. M., Yu, J. J., Shaheen, F., Liszewski, M. K., Mascio, M. D., Migueles, S. A., Connors, M., & O’Doherty, U. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1001300 · Cited by 144
Self-citationBrennan, T. P., Woods, J. O., Sedaghat, A. R., Siliciano, J. D., Siliciano, R. F., & Wilke, C. O. (2009) · Journal of Virology · doi:10.1128/jvi.02568-08 · Cited by 131
Self-citationIdentification of T cell-signaling pathways that stimulate latent HIV in primary cells
Brooks, D. G., Arlen, P. A., Gao, L., Ramirez, C. M., & Zack, J. A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2233345100 · Cited by 117
In Vivo Evidence for Instability of Episomal Human Immunodeficiency Virus Type 1 cDNA
Sharkey, M. E., Triques, K., Kuritzkes, D. R., & Stevenson, M. (2005) · Journal of Virology · doi:10.1128/jvi.79.8.5203-5210.2005 · Cited by 110
Mexas, A. M., Graf, E. H., Pace, M. J., Yu, J. J., Papasavvas, E., Azzoni, L., Busch, M. P., Mascio, M. D., Foulkes, A. S., Migueles, S. A., et al. (2012) · AIDS · doi:10.1097/qad.0b013e32835a5c2f · Cited by 100
Self-citationCritchfield, J. W., Lemongello, D., Walker, D. H., Garcia, J. C., Asmuth, D. M., Pollard, R. B., & Shacklett, B. L. (2007) · Journal of Virology · doi:10.1128/jvi.02535-06 · Cited by 89
Yu, J. J., Wu, T. L., Liszewski, M. K., Dai, J., Swiggard, W. J., Baytop, C., Frank, I., Levine, B. L., Yang, W. P., Theodosopoulos, T. V., et al. (2008) · Virology · doi:10.1016/j.virol.2008.05.030 · Cited by 82
Self-citationAnton, P. A., Mitsuyasu, R. T., Deeks, S. G., Scadden, D. T., Wagner, B. K., Huang, C. A., Macken, C. A., Richman, D. D., Christopherson, C., Borellini, F., et al. (2003) · AIDS · doi:10.1097/00002030-200301030-00008 · Cited by 77
Self-citationGandhi, R. T., Bosch, R. J., Aga, E., Albrecht, M., Demeter, L. M., Dykes, C., Bastow, B., Para, M. F., Lai, J., Siliciano, R. F., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/649569 · Cited by 71
Self-citationSahu, G. K., Paar, D. P., Frost, S. D. W., Smith, M. M., Weaver, S. C., & Cloyd, M. W. (2008) · Journal of Medical Virology · doi:10.1002/jmv.21366 · Cited by 69
Fischer, M., Huber, W., Kallivroussis, A., Ott, P., Opravil, M., Luthy, R. P., Weber, R. K., & Cone, R. W. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.5.1260-1264.1999 · Cited by 69
Murray, J. M., McBride, K. L., Boesecke, C., Bailey, M., Amin, J., Suzuki, K., Baker, D., Zaunders, J., Emery, S., Cooper, D. A., et al. (2012) · AIDS · doi:10.1097/qad.0b013e328350fb3c · Cited by 66
The Regulation of HIV-1 Gene Expression: The Emerging Role of Chromatin
He, G., Ylisastigui, L., & Margolis, D. M. (2002) · DNA and Cell Biology · doi:10.1089/104454902760599672 · Cited by 50
IL-7 as a potential therapy for HIV-1-infected individuals
Nunnari, G., & Pomerantz, R. J. (2005) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.5.11.1421 · Cited by 41
Isolating Mucosal Lymphocytes from Biopsy Tissue for Cellular Immunology Assays
Shacklett, B. L., Critchfield, J. W., & Lemongello, D. (2009) · Methods in molecular biology · doi:10.1007/978-1-59745-170-3_23 · Cited by 31
Cited by
Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure
Ho, Y.-C., Shan, L., Hosmane, N. N., Wang, J., Laskey, S. B., Rosenbloom, D. I. S., Lai, J., Blankson, J. N., Siliciano, J. D., & Siliciano, R. F. (2013) · Cell · doi:10.1016/j.cell.2013.09.020 · Cited by 1,405
Self-citationDefective proviruses rapidly accumulate during acute HIV-1 infection
Bruner, K. M., Murray, A. J., Pollack, R. A., Soliman, M. G., Laskey, S. B., Capoferri, A. A., Lai, J., Strain, M. C., Lada, S. M., Hoh, R., et al. (2016) · Nature Medicine · doi:10.1038/nm.4156 · Cited by 737
Self-citationInternational AIDS Society global scientific strategy: towards an HIV cure 2016
International AIDS Society Towards a Cure Working Group, Deeks, S. G., Lewin, S. R., Ross, A. L., Ananworanich, J., Benkirane, M., Cannon, P., Chomont, N., Douek, D., Lifson, J. D., et al. (2016) · Nature Medicine · doi:10.1038/nm.4108 · Cited by 425
Self-citationCD4+ T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART
Fromentin, R., Bakeman, W., Lawani, M. B., Khoury, G., Hartogensis, W., DaFonseca, S., Killian, M., Epling, L., Hoh, R., Sinclair, E., et al. (2016) · PLOS Pathogens · doi:10.1371/journal.ppat.1005761 · Cited by 422
Self-citationPrecise Quantitation of the Latent HIV-1 Reservoir: Implications for Eradication Strategies
Crooks, A. M., Bateson, R., Cope, A. B., Dahl, N. P., Griggs, M. K., Kuruc, J. D., Gay, C. L., Eron, J. J., Margolis, D. M., Bosch, R. J., et al. (2015) · Journal of Infectious Diseases · doi:10.1093/infdis/jiv218 · Cited by 406
Self-citation
Metadata
- Authors
- Eriksson, S., Graf, E. H., Dahl, V., Strain, M. C., Yukl, S. A., Lysenko, E. S., Bosch, R. J., Lai, J., Chioma, S., Emad, F., Abdel-Mohsen, M., Hoh, R., Hecht, F., Hunt, P., Somsouk, M., Wong, J., Johnston, R., Siliciano, R. F., Richman, D. D., O'Doherty, U., Palmer, S., Deeks, S. G., & Siliciano, J. D.
- Venue
- PLoS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-02-14
- Volume
- 9
- Issue
- 2
- Pages
- e1003174
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- OpenAlex
- W2011208161
- Cited by
- 567
- References
- 85
- FWCI
- 27.32
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.